was significantly greater than the increase in the presence of hyperuricaemia alone (OR = 3.168, 95%CI 2.705, 3.711) or overweight/obesity alone (OR = 3.693, 95% CI 3.503, 3.893). These results were similar across each age group. The same trend was also observed when comparing men and women, though the odds ratios were greater for women. Conclusion: Co-occurrence of hyperuricaemia and overweight/obesity increases risk of hypertension more than either morbidity on its own, and this risk differential is significantly greater in women than men. These findings should be confirmed in other ethnic groups and in longitudinal studies.
INTRODUCTION
Essential or primary hypertension is estimated to cause more than half of the approximately 17 million deaths from cardiovascular disease that occur annually around the world (1) . A systematic review found that in 2008, hypertension was present in approximately 40% of adults over 25 years old all over the world (1) . This prevalence is increasing, particularly in developing countries (2) .
Effective prevention and control of hypertension depend on understanding its risk factors (3) . Uric acid, a metabolic product of purine oxidation in humans, is a risk factor in numerous cardiovascular, metabolic and renal diseases (4) , and its association with hypertension has been known for nearly a century (5) , with more recent studies clearly establishing a link between the two (6) . Obesity is another factor clearly linked to hypertension, and the global epidemic of overweight/obesity due to improvements in living conditions is helping to drive the increasing prevalence of hypertension (7) .
Most studies on risk factors for hypertension have separated hyperuricaemia and overweight/obesity when examining their role in hypertension (6, 7) . This raises the question of whether and how the two morbidities interact in affecting the risk of hypertension onset, progression to more serious cardiovascular disease and patient prognosis. and (c) have no other diseases which can influence the blood pressure significantly.
Demographic data were collected after conducting a complete physical examination, including gender, age, height, weight, blood pressure (after a 15-minute rest) and history of hypertension, drinking and smoking. Blood samples (12-hour fasting) were collected and analysed for levels of uric acid and creatinine level. Subjects were asked not to smoke or drink for the three days prior to the examination. All data were recorded by two researchers independently, following standardized procedures. In the event of discrepancies between the two data sets, the subject was re-examined and/or the archived blood sample was reanalysed.
A subject was classified as having hypertension if he or she had a systolic blood pressure (SBP) ≥ 140 mmHg and/or diastolic blood pressure (DBP) ≥ 90 mmHg during the physical examination (2) or if he or she had previously been diagnosed as hypertensive by healthcare professionals, regardless of whether they were taking antihypertensive medication at the time of the study.
A subject was defined as having hyperuricaemia if he or she had a serum urate level of ≥ 490 mol/L (men) and ≥ 380 mol/L (women). These thresholds are based on diagnostic criteria of the reagents in the Clinical Laboratory of West China Hospital. Overweight/obesity was defined as a body mass index (BMI) ≥ 24 based on the recommendations of the China Obesity Task Force (8) .
Data analysis
Data were entered into Microsoft Excel 2007 and analysed using SPSS 17.0 (IBM, Chicago, USA). Hypertension prevalence rates and odds ratios (ORs) quantifying risk of hypertension, together with associated 95% confidence intervals (CIs), were calculated across all subjects and for different age and gender subgroups. Differences in hypertension prevalence were assessed for significance using the Chi-squared test. Using binary logistic regression, ORs were calculated to assess risk in the presence of hyperuricaemia and/or overweight/obesity; these ORs were always calculated with respect to risk in subjects lacking either condition.
RESULTS
During the study period, 43 556 potentially eligible Han Chinese came into the outpatient Health Management Center. After excluding 1224 individuals (2.8%) due to diseases that might affect blood pressure, such as severe kidney disease, we included 42 332 individuals in the study (24 591 men; 17 731 women; age range, 18 to 98 years). Of this total, 23 734 subjects (56%) neither had hyperuricaemia nor were overweight/obese; 17 772 (42%) were overweight/obese, 8651 (20%) had hypertension and 2678 (6%) had hyperuricaemia. Based on data from the entire study population, hypertension was significantly more prevalent among adults with hyperuricaemia (40.2%) than among those without hyperuricaemia (19.1%, p < 0.001; Table 1 ). The same was true of hypertension prevalence among those who were overweight/obese (32.7%) and those who were not (11.5%, p < 0.001; Table 2 ). Similar results were obtained when we performed subgroup analysis based on gender or age (20-39, 40-59 or ≥ 60 years old)
Li et al We also found that hyperuricaemia was significantly more prevalent among subjects who were overweight/obese (10.5%) than among those who were not (3.3%, p < 0.001; Table 3 ). Similar results were obtained for subgroup analysis based on gender or age. In fact, the dual condition of overweight/obesity with hyperuricaemia (69.5%) was significantly more prevalent among all subjects than overweight/obesity alone (40.1%, p < 0.001; Table 4 ). Similar results were obtained for subgroup analysis based on gender or age.
To quantify the association of risk of hypertension with hyperuricaemia, overweight/obesity and the two conditions together, we generated a logistic regression model to calculate ORs and 95% CIs. Odds ratios indicating the risk of hypertension in the presence of hyperuricaemia and/or overweight/obesity were calculated with respect to risk in subjects lacking either condition. The risk of hypertension was significantly higher in the presence of both hyperuricaemia and overweight/obesity (OR 6.777, 95%CI 6.133, 7.489) than in the presence of hyperuricaemia alone (OR 3.168, 95%CI 2.705, 3.711) or overweight/obesity alone (OR 3.693, 95%CI 3.503, 3.893; Table 6 ). These calculations were then repeated for sub-groups based on gender and age. In all cases, OR was greater in the presence of both hyperuricaemia and overweight/ obesity than in the presence of either morbidity alone; ORs in the presence of both or single morbidities were greater for women than men. In nearly all cases, ORs in the presence of overweight/obesity alone or the combination of hyper-uricaemia and overweight/obesity decreased progressively with age. The exception was ORs in the presence of hyperuricaemia, which peaked in the age group 40-59 years for both men and women.
DISCUSSION
In this large cross-sectional study in southwestern China, we found that hyperuricaemia and overweight/obesity, both known to increase risk of hypertension on their own, interact to increase the risk substantially. These findings, which are consistent with a large study in the United States of America (5), argue for the need for more extensive monitoring of Hyperuricaemia and Obesity on Risk of Hypertension Finally, we observed that hypertension was significantly more prevalent among adults with both hyperuricaemia and overweight/obesity (45.5%) than among those with hyperuricaemia alone (28.1%, p < 0.001) or overweight/obesity alone (31.3 %, p < 0.001; Table 5 ). All these prevalence rates were significantly higher than the rate of hypertension in individuals who neither had hyperuricaemia nor were overweight/obese (11%, p < 0.001). Similar results were obtained with subgroups based on gender or age. hyperuricaemia in populations known to be at risk of hypertension and for public health interventions that take into account the inordinate threat posed by hyperuricaemia and overweight together.
Our results provide large-scale confirmation that hyperuricaemia is associated with hypertension, which may occur by several mechanisms. One is that hyperuricaemia induces vascular endothelial injury (9) which can reduce blood vessel elasticity and cause hypertension. A second mechanism is that hyperuricaemia can cause glomerular artery damage (10) that renders renal tubules sensitive to salt, leading to sodium and water retention that results in high blood pressure (11) . Third, uric acid has been shown to stimulate the renin-angiotensin-aldosterone system directly to increase blood pressure (12) . In animals with uric acidassociated hypertension, treating the hyperuricaemia early can bring blood pressure under control (10, 13) . In humans with hyperuricaemia-associated hypertension, double-blind experiments show that urate-lowering drugs can lower blood pressure (14, 15) .
In overweight and obese individuals, visceral adipose tissue releases free fatty acids into the circulation, which upregulate hepatic gluconeogenesis; this reduces glucose uptake into peripheral tissues, resulting in hyperinsulinaemia. This leads in turn to salt retention in the kidney, raising blood pressure (16) . In addition to hyperinsulinaemia and activation of the renin-angiotensin-aldosterone system in adipose tissue, a recent study suggests that vascular stiffness is also a risk factor in obesity-associated hypertension (17) .
The finding in this study that individuals with both hyperuricaemia and overweight/obesity are at significantly higher risk of hypertension than individuals with either morbidity alone brings together several disparate results in the literature. Hyperuricaemia reduces skeletal muscle glucose uptake (18) (19) (20) which can cause hyperglycaemia. At the same time, elevated levels of uric acid in fat cells can lead to insulin resistance, leading to hyperglycaemia as well as hyperinsulinaemia due to compensatory production of insulin by the pancreas (21) . Simultaneous presence of hyperglycaemia and hyperinsulinaemia, as well as obesity, is a hallmark of metabolic syndrome. Hyperinsulinaemia then increases uric acid reabsorption by renal tubules, leading to hyperuricaemia (22) , thereby creating a vicious cycle. Consistent with these results, we found that individuals who were overweight/obese were more likely to be hyperuricaemic than those who were not overweight/obese and vice versa. These findings suggest that clinicians, epidemiologists and public health practitioners should be aware of the dangerous interaction between hyperuricaemia and obesity, particularly in vulnerable populations such as those with metabolic syndrome.
In our study population, women were at much higher risk of hypertension than men in the presence of one or both morbidities, particularly women aged 40-59 years. Future research should examine these gender-specific effects, and public health interventions should take them into account.
The main advantages of our study are that it involves a large sample from a medical centre that draws patients from a large geographical area in southwestern China, and it is one of the few studies to focus on the interaction between hyperuricaemia and overweight/obesity in influencing the risk of hypertension. Nevertheless, the study has significant limitations: its cross-sectional design, which prevents assessment of causal relationships, the fact that all data came from a single medical centre and were primarily from Han Chinese, and failure to take into account other factors affecting risk of hypertension, such as smoking history, drinking history, diet, stress at home or on the job and family history of hypertension. Future large studies are needed that take into account as many of these factors as possible in other ethnic populations.
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